Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAgronomics Regulatory News (ANIC)

Share Price Information for Agronomics (ANIC)

Share Price is delayed by 15 minutes
Get Live Data
6.55    0.00 (0.00%)
Bid:
6.20
Ask:
6.90
Spread: 0.70 (11.29%)
Market Cap: £70.42m
ANIC Live PriceLast checked at - London Stock Exchange

Intraday Agronomics Share Chart

Net Asset Value(s)

8 Oct 2019 07:00

RNS Number : 0508P
Agronomics Limited
08 October 2019
 

8 October 2019

Agronomics Limited

(the "Company")

Net Asset Value calculation to 30 September 2019

Richard Reed, Chairman, commented: -

"The Net Asset Value ("NAV") calculation for the Company as at closing on 30 September 2019 was 5.50 pence per share, including un-invested cash of £3,463,359. The portfolio is valued under IFRS at bid price. I am pleased to note that the share price of 6.75 pence at 30 September 2019 close represents a premium of 22% to the NAV. Net Assets stand at £6.3 million, including investments of £2.8 million. This quarter's NAV per share represents a decrease of 23% from the previous valuation of 7.17 pence per share, which included un-invested cash of £417,952. The reduction is largely as a result of the increase in issued shares following the fundraise. No management fee is due to Shellbay Investments Limited.

Following completion of a successful fundraise during July 2019, the proceeds are now available for deployment in line with the new investment policy.

On 29 July 2019, the Company completed a subscription of US$ 699,999.54 for 885,739 Series Seed Preferred Shares in Simply Foods, Inc. ("Simply Foods") trading as New Age Meats, a company based in San Francisco, California, USA, that is developing pork-based cultured meat products. The Subscription was part of the first close of the Series Seed funding round to raise a minimum of US$ 2.0 million undertaken by Simply Foods, led by New York-based ff Graphite (V) Venture Capital Fund, LP. The Company was the only European based investor participating in this round, and remains the only UK quoted vehicle offering investors exposure to this rapidly growing sector.

On 29 August 2019, the Company completed a subscription of US$ 749,990 for 40,540 Series A Preferred Shares in BlueNalu, Inc. ("BlueNalu"), a global leader in cellular aquaculture. The subscription increased the Company's existing interest in BlueNalu to approximately 2.59%. The subscription was part of the Series A funding round undertaken by BlueNalu, and co-led by Stray Dog Ventures LLC, Clear Current Capital Fund, LLC, CPT Capital Fund, LLP and New Crop Capital Trust - four prominent investors in the alternative protein sector. The price per share of the subscription represented a multiple uplift of approximately 3.2x since the Company's original investment in BlueNalu of US$250,000 in August 2018.

On 5 September 2019, the Company subscribed for US $150,000 of convertible promissory notes in Bond Pets LLC ("Bond"). Bond makes laboratory-grown meat using fermentation for the pet food market. The subscription would translate to an approximate 3% to 4% equity interest in Bond, dependent on the valuation of Bond upon conversion.

 

Your board continues to evaluate a number of opportunities which show significant growth prospects".

Unaudited to

30 September 2019 £

Fixed Assets

Investments

2,827,203

Current Assets

Uninvested cash

3,463,359

Sundry Debtors

34,355

Current Liabilities

Trade and other creditors

(61,841)

6,263,076

Capital and Reserves

Share Capital

23

Share Premium

6,420,142

Reserves

(157,089)

6,263,076

Shares in Issue

113,795,558

Net Asset Value per share

5.50 pence

 

 

Portfolio Details

Investments as at 30 September 2019

Value

% of Total Portfolio

AgeX Therapeutics Inc

197,193

6.97%

Regent Pacific Group Limited

210,871

7.46%

Portage Biotech Inc

216,845

7.67%

Other quoted holdings

7,627

0.27%

Other unquoted holdings

2,194,667

77.63%

Total

2,827,203

100.00%

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR'). Upon the publication of this announcement via a Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain. 

 

For further information, please contact:

Agronomics Limited

Beaumont Cornish Limited

Optiva Securities Limited

Peterhouse Capital Limited

Britton Financial PR

The Company

Nomad

Joint Broker

Joint Broker

Investor Relations

Denham Eke

+44 (0) 1624 639396

Roland Cornish/James Biddle

+44 (0) 207 628 3396

Jeremy King

+44 (0) 203 137 1904

Lucy Williams

+44 (0) 207 469 0936

 

Tim Blackstone

+44 (0)7957 140416

 

ENDS

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NAVBLBDGUBGBGCR
Date   Source Headline
27th Dec 20237:00 amRNSFinal Results
14th Dec 20237:00 amRNSJim Mellon appointed Executive Chairperson
5th Dec 20233:28 pmRNSInvestee Company Update: Clean Food Group
1st Dec 20237:00 amRNSInvestee Company Update: Clean Food Group
1st Dec 20237:00 amRNSLiberation Labs secures US$ 25 million loan
22nd Nov 20235:05 pmRNSHolding(s) in Company
16th Nov 20232:05 pmRNSSolar Foods Completes EURO 8m Series B Financing
13th Nov 20237:00 amRNSInvestee Company Update: Good Dog Food
9th Nov 20238:09 amRNSUpdate regarding Joint Broker
3rd Nov 20237:05 amRNSNAV calculation as of 30 September 2023
1st Nov 20237:00 amRNSBlueNalu Update: NEOM Signs MoU with BlueNalu
17th Oct 20237:00 amRNSPortfolio Company Update: All G Foods
12th Oct 20239:47 amRNSExercise of Warrants & Total Voting Rights
9th Oct 20237:00 amRNSBlue Naln raises US$33.5m in Series B priced round
22nd Sep 20237:00 amRNSShare Buyback Programme announced
7th Sep 20237:00 amRNSPortfolio Company Update: SuperMeat
21st Aug 20237:00 amRNSPortfolio Company Good Dog Food Update
17th Aug 20237:00 amRNSCellX Opens Chinese Cultivated Meat Pilot Factory
14th Aug 20237:00 amRNSCFG completes £2.3 Million Pre-Series A Financing
9th Aug 20231:06 pmRNSREPLACEMENT: Meatable completes EUR30m funding
8th Aug 20239:05 amRNSMeatable completes EUR35M Series B Financing Round
8th Aug 20238:21 amRNSClean Food Group Collaboration with Alianza
2nd Aug 20237:00 amRNSNet Asset Value calculation at 30 June 2023
18th Jul 20239:14 amRNSFormo Successful Tasting Event
18th Jul 20237:00 amRNSFormo Successful Tasting Event
18th Jul 20237:00 amRNSPortfolio Company Update: Galy Co. Update
11th Jul 202311:33 amRNSExercise of Warrants and TVR
22nd Jun 20231:06 pmRNSCultivated Meat Approved for Sale in the US
22nd Jun 202312:42 pmRNSPortfolio Company CellX Raises US$ 6.5 million
22nd Jun 202310:00 amRNSGood Dog Food raises investment from Pets at Home
16th Jun 20237:00 amRNSUSDA Gives First Label Approval to Lab Grown Meat
15th Jun 20237:00 amRNSAUD 2.5 million investment in HydGene Renewables
14th Jun 20237:00 amRNSAgronomics Appoints Comms Consultancy
1st Jun 20237:00 amRNSReplacement Warrant Final Exercise Dates Extension
31st May 20237:00 amRNSExtension of Warrant Final Exercise Dates
9th May 20232:08 pmRNSDirectors' Dealings
4th May 20237:00 amRNSInvestee Company Update: Good Dog Food
2nd May 202311:38 amRNSNet Asset Value calculation as at 31 March 2023
14th Apr 202310:19 amRNSExercise of Warrants and TVR
12th Apr 202312:00 pmRNSInvestee Company Update: Liberation Labs
28th Mar 20237:00 amRNSDirector/PDMR Shareholding
27th Mar 202311:50 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSFood Fermentation Europe launches
15th Mar 20237:00 amRNSDirectors’ interests in shares
10th Mar 20237:15 amRNSEdison issues update on Agronomics (ANIC)
2nd Mar 20235:50 pmRNSHolding(s) in Company
23rd Feb 20238:00 amRNSANIC invests in Wild Microbes US$3.3m Financing
23rd Feb 20237:00 amRNSAgronomics Welcomes Marisa Drew as a Director
20th Feb 20237:00 amRNSPrecision Fermentation Alliance Formed
9th Feb 20239:00 amRNSAgronomics February 2023 Newsletter

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.